Results 81 to 90 of about 8,357 (184)

Transjugular tricuspid valve‐in‐ring replacement using the novel system under three‐dimensional printing guidance

ESC Heart Failure
Recurrent tricuspid regurgitation after failed ring annuloplasty is associated with high mortality rates and unfavourable clinical outcomes. Transcatheter tricuspid valve‐in‐ring (TVIR) replacement offers an alternative to high‐risk surgical reoperation,
Yiwei Wang, Yang Liu, Jian Yang
doaj   +1 more source

Transcatheter Tricuspid Valve Intervention

Journal of the American College of Cardiology, 2015
O’Neill, William W., O’Neill, Brian P.   +1 more
openaire   +3 more sources

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk. Recently, numerous new medical devices have been proposed and approved for use.
Eugenia Piragine, Vincenzo Calderone, Andrea Messori, Sabrina Trippoli, Sara Veneziano   +4 more
openaire   +3 more sources

Tricuspid Regurgitation: A Review of Current Interventional Management

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Tricuspid regurgitation is a common yet clinically complex problem, traditionally managed with diuretic therapy with no observable mortality benefit. Older studies on surgical intervention observed poor outcomes; however, this clinical reasoning predates
Maxwell Ambrosino, Matthew Sangoi, Nasser Monzer, Brett Irving, Paul Fiorilli, Benjamin Khazan, Sheldon Goldberg   +6 more
doaj   +1 more source

Clinical Outcomes Following Transcatheter Tricuspid Valve Replacement – A Meta-Analysis

Structural Heart
Background: Tricuspid regurgitation (TR) is associated with substantial morbidity and mortality, yet it remains an undertreated entity. Transcatheter tricuspid valve replacement (TTVR) has emerged as a promising therapeutic option, with multiple novel ...
Taha Hatab, MD, Osamah Badwan, MD, Radwan Alkhatib, MD, Akiva Rosenzveig, MD, Mangesh Kritya, MD, Faysal Massad, MD, Saeid Mirzai, DO, Serge Harb, MD, Grant Reed, MD, MSc, Amar Krishnaswamy, MD, Rishi Puri, MD, PhD, Samir R. Kapadia, MD   +11 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Transcatheter dual-device closure for symptomatic iatrogenic atrial septal defect following bioprosthetic mitral valve replacement: a case report

Frontiers in Medical Technology
Iatrogenic atrial septal defect (iASD) is a relatively common complication after cardiac surgical or catheter-based procedures involving transseptal access.
Ping-an Lian, Ping-an Lian, Shan-fu Liang, Shan-fu Liang, Fei Xie, Fei Xie, Shuai Cheng, Shuai Cheng, Zhan-zhan Zhu, Zhan-zhan Zhu, Yun-fei Zhao, Yun-fei Zhao, Lei Yin, Lei Yin, Shen-wei Zhang, Shen-wei Zhang   +15 more
doaj   +1 more source

Mitral regurgitation evolution after transcatheter tricuspid valve interventions - a sub-analysis of the TriValve Registry [PDF]

Aims Transcatheter tricuspid valve interventions (TTVI) are increasingly used to treat patients with significant tricuspid regurgitation (TR). The evolution of concurrent mitral regurgitation (MR) severity after TTVI is currently unknown and may be ...
Sievert, Horst, Federico De Marco, Philipp Lurz, Hahn, Rebecca T, Kim A Connelly, Webb, John, Gianluca Pontone, Alessandrini, Hannes, Rommel, Karl-Philipp, Fabien Praz, Russo, Giulio, Stephan von Bardeleben, Ralph, Paolo Denti, Marianna Adamo, John Webb, Kresoja, Karl-Patrik, Neil Fam, Ralph Stephan von Bardeleben, Thiele, Holger, Tang, Gilbert, Rodrigo Estevez-Loureiro, Nickenig, Georg, De Marco, Federico, Schofer, Joachim, Dominique Himbert, Ludwig, Sebastian, Rebecca T Hahn, Fam, Neil, Edith Lubos, Alberto Pozzoli, Lubos, Edith, Denti, Paolo, Lurz, Philipp, Vanessa Monivas, Estevez-Loureiro, Rodrigo, Martin Leon, Stephan Windecker, Hausleiter, Joerg, Stankowski, Kamil, Kalbacher, Daniel, Metra, Marco, Taramasso, Maurizio, Maisano, Francesco, Joachim Schofer, Karl-Patrik Kresoja, Cannata, Francesco, Daniel Braun, Harr, Claudia, Daniel Kalbacher, Sebastian Ludwig, Alessandro Sticchi, Karl-Philipp Rommel, Claudia Harr, Sticchi, Alessandro, Himbert, Dominique, Kamil Stankowski, Joerg Hausleiter, Windecker, Stephan, Latib, Azeem, Rodes-Cabau, Josep, Leon, Martin, Francesco Cannata, Pozzoli, Alberto, Praz, Fabien, Hannes Alessandrini, Connelly, Kim A, Josep Rodes-Cabau, Azeem Latib, Giulio Russo, Gilbert Tang, Holger Thiele, Andreas, Martin, Braun, Daniel, Pedrazzini, Giovanni, Adamo, Marianna, Martin Andreas, Marco Metra, Monivas, Vanessa, Francesco Maisano, Pontone, Gianluca, Giovanni Pedrazzini, Horst Sievert, Maurizio Taramasso, Georg Nickenig   +83 more
core   +3 more sources

Valvular Heart Disease Interventional Trials From 2000 to 2024

JACC: Advances
Background: Valvular heart disease (VHD) is a growing contributor to global cardiovascular morbidity, especially in aging populations. As transcatheter therapies expand, assessing enrollment trends and demographic representation is essential for ...
Frederick Berro Rivera, MD, Chieh-Mei Tsai, MD, Polyn Luz S. Pine, MD, MBA, Nicole Tesoro, MD, John Vincent Magalong, MD, Nathan Ross B. Bantayan, BSc, Christine J. Lin, BA, Gabriel A. Tangco, MD, MBA, Abdullah Al-Abcha, MD, Mandeep Singh, MD, Mayra Guerrero, MD   +10 more
doaj   +1 more source

First-in-man Experience of a New Transcatheter Edge-to-edge Repair System Neoblazar in Patients With Severe Tricuspid Regurgitation

Cardiology Discovery
Objective:. Severe tricuspid regurgitation frequently leads to increased mortality and a poor prognosis. Transcatheter edge-to-edge repair (TEER) for tricuspid valve regurgitation has been reported as a safe alternative to traditional open-heart surgery.
Xiang Chen, Da Zhu, Maolong Su, Xu Chen, Pianpian Yan, Hongmei Wen, Bin Wang, Nianguo Dong, Xiangbin Pan, Yan Wang   +9 more
doaj   +1 more source